Alyeska Investment Group, L.P. 13D and 13G filings for Unity Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:35 pm Sale |
2024-09-30 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,667,914 9.990% |
-8,904 (-0.53%) |
Filing |
| 2024-02-14 1:52 pm Purchase |
2023-12-31 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,676,818 9.990% |
257,818 (+18.17%) |
Filing |
| 2023-02-14 2:07 pm Purchase |
2022-12-31 | 13G | Unity Biotechnology, Inc. UBX |
Alyeska Investment Group, L.P. | 1,419,000 9.990% |
1,419,000 (New Position) |
Filing |